P13 BABRAHAM
From LipidomicsWiki
(Difference between revisions)
Line 7: | Line 7: | ||
|myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through association with Birmingham University access to human samples and | |myContribution=The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through association with Birmingham University access to human samples and | ||
DNA array facilities. | DNA array facilities. | ||
- | |myTaskforces= | + | |myTaskforces=[[Task_Force_I|Task Force I]], [[Task_Force_II|Task Force II]], [[Task_Force_VI|Task Force VI]], [[Task_Force_VII|Task Force VII]], and [[Task_Force_IX|Task Force IX]] |
- | |myWorkpackages= | + | |myWorkpackages=[[WP4|WP4]] |
}}<br> <br> | }}<br> <br> | ||
[[Category:Project_organisation]] | [[Category:Project_organisation]] |
Revision as of 12:41, 17 June 2011
Institution | The Babraham Institute, Cambridge - Michael Wakelam | |
Principal investigator | {{{myPrincipal_investigator}}} | |
Country | United Kingdoms | |
Beneficiary Number | P13 | |
About us | ||
Contributions | The Wakelam laboratory brings expertise in the study of signal transduction pathways to LipidomicNet. The lab has developed HPLC-MS methods for the analysis of lipids including the phosphoinositides. The lab has expertise in the generation of genetically modified mouse models and through association with Birmingham University access to human samples and DNA array facilities. | |
Member of Taskforces | Task Force I, Task Force II, Task Force VI, Task Force VII, and Task Force IX | |
Member of Workpackages | WP4 |